Level of adherence to treatment of patients with systemic lupus erythematosus in a reference center
PDF (Spanish)

Keywords

systemic lupus erythe-matosus
adherence to treatment
therapeutic compliance

Notice: Deprecated: The template at plugins/themes/healthSciences/templates/plugins/generic/citationStyleLanguage/citationblock.tpl has moved and will not be found in the future. in /home/u494646269/domains/revista.spr.org.py/public_html/lib/pkp/classes/plugins/Plugin.php on line 468

How to Cite

1.
Level of adherence to treatment of patients with systemic lupus erythematosus in a reference center. Rev. parag. reumatol. [Internet]. 2022 Dec. 15 [cited 2025 Sep. 17];8(2):67-71. Available from: https://www.revista.spr.org.py/index.php/spr/article/view/151

Abstract

Introduction: systemic lupus erythematosus is an autoimmune disease that can affect multiple organs. Appropriate treatment decreases the risk of organ injury or its progression in those who already have organic involvement.

Objectives: determine the level of adherence of patients with systemic lupus erythematosus of patients who consult at the National Hospital, Itauguá, period 2022 from January to March.

Methods: It was an observational, descriptive, prospective study. A survey was conducted using a validated questionnaire for rheumatic diseases. All patients who consulted during the study period were included.

Results: the sample consisted of 100 patients, 96% were female, the average age was 35 years. 48% comes from the interior and the rest from the central department. The time of evolution of the disease in most is 1 to 5 years. 47% have other comorbidities, the most frequent being arterial hypertension. The adherence level was 68%. The presence of comorbidity is related to adherence (p <0.05), however, source of employment, monthly income, health insurance, age, children, follow-up and the number of medications did not have statistical significance for adherence (p >0.05).

Conclution: the sample was composed of young patients of childbearing age, most of them female. The level of adherence to treatment in our center was 68% and the presence of comorbidities is associated with better adherence.

PDF (Spanish)

References

(1) Narváez J. Lupus eritematoso sistémico 2020. Med Clin (Barc). 2020 Dec 11;155(11):494–501.

(2) Manuel Bermúdez Marrero W, Yanelis Vizcaino Luna D, Alejandro Bermúdez Marrero W. Lupus eritematoso sistémico. Acta Médica del Cent [Internet]. 2017 [cited 2022 Mar 3];11(1). Available from: http://www.revactamedicacentro.sld.cu82

(3) Mehat P, Atiquzzaman M, Esdaile JM, AviÑa-Zubieta A, De Vera MA. Medication Nonadherence in Systemic Lupus Erythematosus: A Systematic Review. Arthritis Care Res (Hoboken) [Internet]. 2017 Sep 21 [cited 2022 Mar 3];69(11):1706–13. Available from: https:// europepmc.org/article/MED/28086003

(4) Georgopoulou S, Nel L, Sangle SR, D’Cruz DP. Physician–patient interaction and medication adherence in lupus nephritis. Lupus [Internet]. 2020 Sep 1 [cited 2022 Mar 3];29(10):1168–78. Available from: https://journals.sagepub.com/doi abs/10.1177/0961203320935977

(5) Daleboudt GMN, Broadbent E, McQueen F, Kaptein AA. Intentional and unintentional treatment nonadherence in patients with systemic lupus erythematosus. Arthritis Care Res (Hoboken) [Internet]. 2011 Mar 1 [cited 2022 Mar 3];63(3):342–50. Available from: https:// onlinelibrary.wiley.com/doi/full/10.1002/acr.20411

(6) Chambers SA, Raine R, Rahman A, Isenberg D. Why do patients with systemic lupus erythematosus take or fail to take their pres- cribed medications? A qualitative study in a UK cohort. Rheumatology [Internet]. 2009 Mar 1 [cited 2022 Mar 3];48(3):266–

(7) 71. Available from: https://academic.oup.com/rheumatology/ article/48/3/266/1786852

(8) Prados-Moreno S, Sabio JM, Pérez-Mármol JM, Navarrete-Navarrete N, Peralta-Ramírez MI. Adherencia al tratamiento en pacientes con lupus eritematoso sistémico. Med Clin (Barc). 2018 Jan 12;150(1): 8–15.

(9) Cevallos Guerrero A, Fernández HÁ, Jimbo Sotomayor R, Guevara GC, Mera Orces D, Naranjo-Saltos F. Treatment adherence in patients with diffuse neuropsychiatric disorders associated with systemic lupus erythematosus. Rev Colomb Reumatol. 2022 Jan 1;29(1):26–30.

(10) Du X; Chen H; Zhuang Y; Zhao Q; Shen B. Adherencia a la medicación en pacientes chinos con lupus eritematoso sistémico. [Internet]. [cited 2022 Mar 3]. Available from: https://reference. medscape.com/medline/abstract/30601165

(11) Mendoza-Pinto C, García-Carrasco M, Campos-Rivera S, Munguía- Realpozo P, Etchegaray-Morales I, Ayón-Aguilar J, et al. Medication adherence is influenced by resilience in patients with systemic lupus erythematosus. Lupus [Internet]. 2021 Apr 1 [cited 2022 Mar 3];30(7):1051–7. Available from: https://europepmc.org/ article/MED/33794703

(12) Hartman EAR, van Royen-Kerkhof A, Jacobs JWG, Welsing PMJ, Fritsch-Stork RDE. Performance of the 2012 Systemic Lupus Inter- national Collaborating Clinics classification criteria versus the 1997 American College of Rheumatology classification criteria in adult and juvenile systemic lupus erythematosus. A systematic review and meta-analysis. Autoimmun Rev [Internet]. 2018 Mar 1 [cited 2022 Mar 28];17(3):316–22. Available from: https://pubmed. ncbi.nlm.nih.gov/29366725/

(13) Fernández-Avila DG, Accini M, Tobón M, Moreno S, Rodríguez V, Gutiérrez JM. Validación y calibración al español del cuestionario CQR (Compliance Questionnaire on Rheumatology) para la medición de adherencia a la terapia antirreumática en un grupo de pacientes colombianos con artritis reumatoide. Rev Colomb Reumatol. 2019 Apr 1;26(2):105–10.

(14) Solis Cartas U, Martínez Larrarte JP, Valdés González JL, Gafas González C. Percepción de la calidad de vida en pacientes con lupus eritematoso sistémico. Estudio de cinco años. Rev Colomb Reumatol. 2021 Jul 30;

(15) Coronado-Alvarado C, Gámez-Saiz I, Sotelo-Cruz N, Coronado- Alvarado C, Gámez-Saiz I, Sotelo-Cruz N. Características clínicas y comorbilidades de pacientes con lupus eritematoso sistémico en niños y adultos. Acta pediátrica México [Internet]. 2018 Jan 16 [cited 2022 Mar 27];39(1):1–12. Available from: http://www.scielo. org.mx/scielo.php?script=sci_arttext&pid=S018623912018000100 001&lng=es&nrm=iso&tlng=es

(16) Melgarejo Paniagua PA, Denis Doldán AE, Ferreira Gaona MI, Díaz Reissner CV. Complicaciones en pacientes con lupus eritematoso sistémico. DEL Nac. 2015 Jun 10;7(1):28–31.

Downloads

Download data is not yet available.